| pubmed-article:21419609 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C0025344 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C0006736 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C0486616 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C0439234 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C2347804 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C1561960 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C1522492 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C1948053 | lld:lifeskim |
| pubmed-article:21419609 | lifeskim:mentions | umls-concept:C0621015 | lld:lifeskim |
| pubmed-article:21419609 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:21419609 | pubmed:dateCreated | 2011-7-5 | lld:pubmed |
| pubmed-article:21419609 | pubmed:abstractText | Kidney stones are a common problem for which inadequate prevention exists. We recruited ten recurrent kidney stone formers with documented calcium oxalate stones into a two phased study to assess safety and effectiveness of Cystone(®), an herbal treatment for prevention of kidney stones. The first phase was a randomized double-blinded 12 week cross over study assessing the effect of Cystone(®) vs. placebo on urinary supersaturation. The second phase was an open label one year study of Cystone(®) to determine if renal stone burden decreased, as assessed by quantitative and subjective assessment of CT. Results revealed no statistically significant effect of Cystone(®) on urinary composition short (6 weeks) or long (52 weeks) term. Average renal stone burden increased rather than decreased on Cystone(®). Therefore, this study does not support the efficacy of Cystone(®) to treat calcium oxalate stone formers. Future studies will be needed to assess effects on stone passage, or on other stone types. | lld:pubmed |
| pubmed-article:21419609 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419609 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21419609 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419609 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21419609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419609 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21419609 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21419609 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:21419609 | pubmed:issn | 1618-095X | lld:pubmed |
| pubmed-article:21419609 | pubmed:author | pubmed-author:EricksonS BSB | lld:pubmed |
| pubmed-article:21419609 | pubmed:author | pubmed-author:VrtiskaT JTJ | lld:pubmed |
| pubmed-article:21419609 | pubmed:author | pubmed-author:LieskeJ CJC | lld:pubmed |
| pubmed-article:21419609 | pubmed:copyrightInfo | Copyright © 2011 Elsevier GmbH. All rights reserved. | lld:pubmed |
| pubmed-article:21419609 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21419609 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:21419609 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:21419609 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21419609 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21419609 | pubmed:pagination | 863-7 | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:meshHeading | pubmed-meshheading:21419609... | lld:pubmed |
| pubmed-article:21419609 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21419609 | pubmed:articleTitle | Effect of Cystone® on urinary composition and stone formation over a one year period. | lld:pubmed |
| pubmed-article:21419609 | pubmed:affiliation | Division of Nephrology & Hypertension, Ma-E19, Mayo Clinic, Rochester, MN 55905, USA. erickson.stephen@mayo.edu | lld:pubmed |
| pubmed-article:21419609 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21419609 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21419609 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21419609 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
